Journal article icon

Journal article

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.

Abstract:

OBJECTIVES: To review the evidence of the clinical and cost-effectiveness of anakinra, an interleukin-1 receptor antagonist (IL-1Ra), for the treatment of rheumatoid arthritis (RA) in adults. DATA SOURCES: Electronic bibliographic databases. Scrip, Food and Drug Administration (FDA) submissions for new drug applications, European Agency for the Evaluation of Medicinal Products (EMEA) reports and the pharmaceutical company submission to the National Institute for Clinical Excellence. REVIEW ME...

Expand abstract

Actions


Authors


Jobanputra, P More by this author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Primary Care Health Sciences, PHC-EBM
Journal:
Health technology assessment (Winchester, England)
Volume:
8
Issue:
18
Pages:
iii-105
Publication date:
2004-05-05
EISSN:
2046-4924
ISSN:
1366-5278
URN:
uuid:ff90a6a2-948f-415b-ba82-736dbb227f9a
Source identifiers:
116338
Local pid:
pubs:116338

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP